Cargando…
Bacteria and cells as alternative nano-carriers for biomedical applications
INTRODUCTION: Nano-based systems have received a lot of attention owing to their particular properties and, hence, have been proposed for a wide variety of biomedical applications. These nanosystems could be potentially employed for diagnosis and therapy of different medical issues. Although these n...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802895/ https://www.ncbi.nlm.nih.gov/pubmed/35076351 http://dx.doi.org/10.1080/17425247.2022.2029844 |
_version_ | 1784642767596552192 |
---|---|
author | García-Álvarez, Rafaela Vallet-Regí, María |
author_facet | García-Álvarez, Rafaela Vallet-Regí, María |
author_sort | García-Álvarez, Rafaela |
collection | PubMed |
description | INTRODUCTION: Nano-based systems have received a lot of attention owing to their particular properties and, hence, have been proposed for a wide variety of biomedical applications. These nanosystems could be potentially employed for diagnosis and therapy of different medical issues. Although these nanomaterials are designed for specific tasks, interactions, and transformations when administered to the human body affect their performance and behavior. In this regard, bacteria and other cells have been presented as alternative nanocarriers. These microorganisms can be genetically modified and customized for a more specific therapeutic action and, in combination with nanomaterials, can lead to bio-hybrids with a unique potential for biomedical purposes. AREAS COVERED: Literature regarding bacteria and cells employed in combination with nanomaterials for biomedical applications is revised and discussed in this review. The potential as well as the limitations of these novel bio-hybrid systems are evaluated. Several examples are presented to show the performance of these alternative nanocarriers. EXPERT OPINION: Bio-hybrid systems have shown their potential as alternative nanocarriers as they contribute to better performance than traditional nano-based systems. Nevertheless, their limitations must be studied, and advantages and drawbacks assessed before their application to medicine. |
format | Online Article Text |
id | pubmed-8802895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-88028952022-02-01 Bacteria and cells as alternative nano-carriers for biomedical applications García-Álvarez, Rafaela Vallet-Regí, María Expert Opin Drug Deliv Review INTRODUCTION: Nano-based systems have received a lot of attention owing to their particular properties and, hence, have been proposed for a wide variety of biomedical applications. These nanosystems could be potentially employed for diagnosis and therapy of different medical issues. Although these nanomaterials are designed for specific tasks, interactions, and transformations when administered to the human body affect their performance and behavior. In this regard, bacteria and other cells have been presented as alternative nanocarriers. These microorganisms can be genetically modified and customized for a more specific therapeutic action and, in combination with nanomaterials, can lead to bio-hybrids with a unique potential for biomedical purposes. AREAS COVERED: Literature regarding bacteria and cells employed in combination with nanomaterials for biomedical applications is revised and discussed in this review. The potential as well as the limitations of these novel bio-hybrid systems are evaluated. Several examples are presented to show the performance of these alternative nanocarriers. EXPERT OPINION: Bio-hybrid systems have shown their potential as alternative nanocarriers as they contribute to better performance than traditional nano-based systems. Nevertheless, their limitations must be studied, and advantages and drawbacks assessed before their application to medicine. Taylor & Francis 2022-01-25 /pmc/articles/PMC8802895/ /pubmed/35076351 http://dx.doi.org/10.1080/17425247.2022.2029844 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Review García-Álvarez, Rafaela Vallet-Regí, María Bacteria and cells as alternative nano-carriers for biomedical applications |
title | Bacteria and cells as alternative nano-carriers for biomedical applications |
title_full | Bacteria and cells as alternative nano-carriers for biomedical applications |
title_fullStr | Bacteria and cells as alternative nano-carriers for biomedical applications |
title_full_unstemmed | Bacteria and cells as alternative nano-carriers for biomedical applications |
title_short | Bacteria and cells as alternative nano-carriers for biomedical applications |
title_sort | bacteria and cells as alternative nano-carriers for biomedical applications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802895/ https://www.ncbi.nlm.nih.gov/pubmed/35076351 http://dx.doi.org/10.1080/17425247.2022.2029844 |
work_keys_str_mv | AT garciaalvarezrafaela bacteriaandcellsasalternativenanocarriersforbiomedicalapplications AT valletregimaria bacteriaandcellsasalternativenanocarriersforbiomedicalapplications |